Regulatory Mechanisms in Biosystems,
Journal Year:
2023,
Volume and Issue:
14(3), P. 341 - 348
Published: June 30, 2023
Chronic
cerebral
hypoperfusion
is
a
widespread
pathological
condition
caused
by
chronically
reduced
blood
flow
leading
to
brain
damage,
but
the
specific
molecular
mechanisms
that
regulate
these
phenomena
remain
poorly
understood.
In
this
study,
we
investigated
damage
and
neuronal
DNA
injury
in
vulnerable
region
of
brain,
hippocampus,
as
well
involvement
apolipoprotein
E
(ApoE),
sirtuins
1
(SIRT1)
3
(SIRT3)
types
insulin-like
growth
factor
(IGF-1)
pathogenetic
mice
with
chronic
permanent
occlusion
left
unilateral
common
carotid
artery.
Male
C57/6j
(C57,
wild
type)
ApoE(-/-)
were
divided
into
four
experimental
groups
(10
per
group):
sham-operated
С57,
С57
hypoperfusion,
mice,
hypoperfusion.
Our
results
showed
number
damaged
neurons
hippocampus
at
8
weeks
after
surgical
manipulation
increased
both
more
pronounced
rates
than
C57
mice.
However,
ApoE
deficiency
moderate
was
accompanied
higher
level
undamaged
(class
0)
low
maximally
4)
cell
nuclei
contrast
group
C57.
ApoE-deficient
expression
SIRT1,
SIRT3,
IGF-1
found.
preserved,
significantly
comparison
The
obtained
indicate
leads
downregulation
SIRT3
brain;
lack
cytoprotection
enhanced
may
participate
damage.
Translational Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
12(1)
Published: Nov. 2, 2023
Abstract
Cognitive
impairment
is
a
multifactorial
and
multi-step
pathological
process
that
places
heavy
burden
on
patients
the
society.
Neuroinflammation
one
of
main
factors
leading
to
cognitive
impairment.
The
inflammasomes
are
multi-protein
complexes
respond
various
microorganisms
endogenous
danger
signals,
helping
initiate
innate
protective
responses
in
inflammatory
diseases.
NLRP3
produce
proinflammatory
cytokines
(interleukin
IL-1β
IL-18)
by
activating
caspase-1.
In
this
review,
we
comprehensively
describe
structure
functions
inflammasome.
We
also
explore
intrinsic
relationship
between
inflammasome
impairment,
which
involves
immune
cell
activation,
apoptosis,
oxidative
stress,
mitochondrial
autophagy,
neuroinflammation.
Finally,
antagonists
as
targeted
therapies
improve
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: June 2, 2023
Cognitive
impairment
is
a
major
global
disease,
manifests
as
decline
in
cognitive
functioning
and
endangers
the
health
of
population
worldwide.
The
incidence
has
increased
rapidly
with
an
increasingly
aging
population.
Although
mechanisms
have
partly
been
elucidated
development
molecular
biological
technology,
treatment
methods
are
very
limited.
As
unique
form
programmed
cell
death,
pyroptosis
highly
pro-inflammatory
closely
associated
progression
impairment.
In
this
review,
we
discuss
briefly
research
progress
on
relationship
between
its
potential
therapeutic
values,
to
provide
reference
for
field
Cells,
Journal Year:
2025,
Volume and Issue:
14(2), P. 74 - 74
Published: Jan. 8, 2025
Despite
the
presentation
of
similar
psychological
symptoms,
dysfunction
secondary
to
brain
injury
exhibits
markedly
lower
treatment
efficacy
compared
injury-independent
dysfunction.
This
gap
remains
evident,
despite
extensive
research
efforts.
review
integrates
clinical
and
preclinical
evidence
provide
a
comprehensive
overview
neurobiological
mechanisms
underlying
neuropsychological
disorders,
focusing
on
role
key
regions
in
emotional
regulation
across
various
forms
injuries.
It
examines
therapeutic
interventions
mechanistic
targets,
with
primary
goal
identifying
pathways
for
targeted
treatments.
The
highlights
promising
avenues
addressing
injury-associated
dysfunction,
emphasizing
Nrf2,
neuropeptides,
nonpharmacological
therapies
as
multi-mechanistic
capable
modulating
upstream
mediators
address
complex
interplay
factors
injury.
Additionally,
it
identifies
sexually
dimorphic
potential
areas
further
exploration
advocates
detailed
investigations
into
sex-specific
patterns
uncover
additional
contributors
these
disorders.
Furthermore,
underscores
significant
gaps,
particularly
inadequate
consideration
interactions
among
causal
factors,
environmental
influences,
individual
susceptibilities.
By
this
provides
new
insights
calls
paradigm
shift
toward
more
context-specific
integrative
approach
developing
following
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
224, P. 111305 - 111305
Published: March 16, 2025
Pyroptosis
has
been
reported
to
play
a
pathogenic
role
in
neonatal
hypoxic-ischemic
brain
damage
(HIBD).
Absence
melanoma
2
(AIM2)
is
an
inflammasome
involved
pyroptosis.
This
study
aimed
investigate
the
of
AIM2
hypoxic-ischemia
(HI)-induced
pyroptosis
and
rat
HIBD
model.
In
vivo,
we
injected
lentivirus
that
overexpressed
or
knocked
down
into
lateral
ventricle
rats
within
24h
after
birth
prepared
7-day
Sprague
Dawley
(SD)
vitro,
transfected
lentiviruses
overexpressing
knocking
cultured
primary
neurons
established
oxygen/glucose
deprivation/reoxygenation
(OGD/R)
2,3,5-triphenyltetrazolium
chloride
(TTC)
staining
was
used
determine
infarct
size.
Hematoxylin
eosin
Nissl
were
evaluate
morphological
changes
damaged
brain.
Cell
Counting
Kit-8
(CCK-8)
lactate
dehydrogenase
(LDH)
assays
cell
viability
toxicity.
observed
using
transmission
electron
microscopy.
expression
significantly
increased
HI-induced
cortex
rats.
Lentivirus-mediated
overexpression
aggravates
injury
OGD/R-induced
neuronal
vivo
vitro.
The
lentivirus-mediated
knockdown
reversed
these
adverse
effects.
addition,
whereas
suppressed
via
AIM2/Caspase-1/GSDMD
pathway.
These
findings
show
upregulation
activates
plays
HIBD.
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(5), P. 467 - 467
Published: May 7, 2024
B355252
is
a
small
molecular
compound
known
for
potentiating
neural
growth
factor
and
protecting
against
neuronal
cell
death
induced
by
glutamate
in
vitro
cerebral
ischemia
vivo.
However,
its
other
biological
functions
remain
unclear.
This
study
aims
to
investigate
whether
suppresses
neuroinflammatory
responses
the
brain.
C57BL/6j
mice
were
intraperitoneally
injected
with
single
dosage
of
lipopolysaccharide
(LPS,
1
mg/kg)
induce
inflammation.
(1
intervention
was
started
two
days
prior
LPS
injection.
The
animal
behavioral
changes
assessed
pre-
post-LPS
injections.
brains
harvested
at
4
24
h
injection,
histological,
biochemical,
cytokine
array
outcomes
examined.
Results
showed
that
improved
LPS-induced
deterioration,
mitigated
brain
tissue
damage,
suppressed
activation
microglial
astrocytes.
Furthermore,
reduced
protein
levels
key
pyroptotic
markers
TLR4,
NLRP3,
caspase-1
inhibited
increases
IL-1β,
IL-18,
cytokines.
In
conclusion,
demonstrates
potent
anti-neuroinflammatory
effect
vivo,
suggesting
potential
therapeutic
value
warrants
further
investigation.
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 14, 2024
Abstract
Background
Chronic
cerebral
ischemia
(CCI)
is
a
significant
health
issue
characterized
by
hypoperfusion
due
to
damage
or
occlusion
of
the
carotid
arteries.
CCI
may
lead
progressive
cognitive
impairment
that
considered
as
prelude
neurodegenerative
diseases,
including
dementia
and
Alzheimer's
disease
(AD).
Endothelial
progenitor
cells
(EPCs)
have
been
implicated
in
vascular
repair
ischemic
cerebrovascular
primarily
differentiating
into
endothelial
(ECs)
through
paracrine
effects.
However,
clinical
transplantation
stem
cell
therapies
remains
limited.
In
this
study,
we
investigated
effects
EPC-derived
conditioned
medium
(EPC-CM)
on
impaired
vasculature
neurological
function
rodent
model
mechanism
involved.
Methods
EPC-CM
was
analyzed
cytokine
array
identify
key
factors
involved
angiogenesis
cellular
senescence.
The
candidate
were
validated
vitro
using
oxygen–glucose
deprivation
(OGD)-injured
ECs
EPCs.
therapeutic
identified
factor
further
examined
rat
CCI,
which
induced
bilateral
internal
artery
ligation
(BICAL).
administered
via
intracisternal
injection
one
week
post
BICAL.
microvasculature
neurobehavior
rats
three
weeks
after
Results
Macrophage
migration
inhibitory
(MIF)
EPC-CM.
Recombinant
MIF
protein
promoted
prevented
senescence
injured
EPCs
ECs.
effect
similar
These
diminished
when
co-treated
with
MIF-specific
antibody
(Ab).
Additionally,
vascular,
motor,
improvements
observed
BICAL
treated
abolished
Ab.
Furthermore,
found
anti-senescence
activating
AKT
pathway.
Inhibition
pathway
protective
study.
Conclusions
We
demonstrated
protected
brain
from
chronic
injury
functional
recovery
MIF-mediated
findings
suggest
holds
potential
novel
cell-free
approach
for
treating
actions
MIF.